Opportunity Information: Apply for PA 09 100
Apply for PA 09 100
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "Energy Efficiency and Renewable Energy System Technology Research and Development (SBIR R43/R44)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.121 Oral Diseases and Disorders Research 93.273 Alcohol Research Programs 93.279 Drug Abuse and Addiction Research Programs 93.389 National Center for Research Resources 93.839 Blood Diseases and Resources Research 93.855 Allergy, Immunology and Transplantation Research 93.856 Microbiology and Infectious Diseases Research 93.859 Biomedical Research and Research Training 93.866 Aging Research.
- This funding opportunity was created on Feb 12, 2009 and posted on Feb 12, 2009.
- Applicants must submit their applications by Jan 7, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Small businesses.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Energy Efficiency and Renewable Energy System Technology Research and Development opportunity (Funding Opportunity Number PA 09 100) is an NIH Small Business Innovation Research (SBIR) grant announcement designed to push small businesses to develop and validate technologies that connect biomedical research with energy efficiency or renewable energy systems. The underlying driver is the Energy Independence and Security Act of 2007 (Public Law 110-140), signed on December 19, 2007, which directs federal SBIR/STTR agencies to give high priority, whenever possible and appropriate, to research and development projects that improve energy efficiency or advance renewable energy systems. NIH translated that direction into this SBIR-focused funding pathway by explicitly encouraging U.S. small business concerns to submit projects where biomedical science and technology development meaningfully intersect with energy-related goals, such as reducing energy consumption in health-related settings, improving efficiency of biomedical devices or lab processes, or enabling renewable energy integration in biomedical or healthcare applications.
This announcement uses the SBIR grant mechanisms R43 and R44 and supports multiple SBIR application tracks: Phase I (early feasibility and proof of concept), Phase II (full R&D and development toward commercialization), Fast Track (a combined Phase I/Phase II submission intended to speed transition when a clear development path exists), and Phase II Competing Renewal (noted as NIH-only), which can support additional work beyond the initial Phase II when justified by progress and remaining development needs. The FOA also notes that it runs in parallel with a companion announcement of the same scientific scope for the Small Business Technology Transfer (STTR) program (PA 09 101; mechanisms R41/R42). In practical terms, that parallel structure means applicants choosing between SBIR and STTR can pursue essentially the same topic space, but under different program rules (for example, SBIR generally centers the small business as the primary R&D performer, while STTR more explicitly requires collaboration with a nonprofit research institution).
Eligibility is limited to U.S. small businesses. The opportunity is categorized as discretionary funding and uses a grant instrument type, with no cost-sharing or matching requirement. NIH is the sponsoring agency, and the funding activity category is listed under education and health, reflecting the biomedical focus even though the emphasis includes energy efficiency and renewable energy system relevance. The announcement is also associated with a broad set of CFDA program areas that signal which NIH domains could reasonably support work under this umbrella, including oral diseases and disorders (93.121), alcohol research (93.273), drug abuse and addiction (93.279), national center for research resources (93.389), blood diseases and resources (93.839), allergy/immunology/transplantation (93.855), microbiology and infectious diseases (93.856), biomedical research and research training (93.859), and aging research (93.866). That spread is a clue that NIH was open to energy-related R&D concepts as long as they were grounded in biomedical research needs and fit within an NIH institute or center mission.
In terms of funding levels and award counts, NIH does not commit to a fixed number of awards or a specific total dollar amount in the summary provided. Instead, awards are explicitly contingent on the availability of funds and on receiving a sufficient volume of high-quality, meritorious applications. The eventual number of awards and total funding depend on the quality, duration, and cost structure of the proposals that come in, which is typical language for NIH grant announcements and signals that competition and scientific/technical merit are the main drivers. The announcement was posted and created on February 12, 2009, with an original closing date of January 7, 2012, and it was archived on February 7, 2012, meaning it is no longer active but remains part of the historical NIH funding record.
For applicants and stakeholders, the main takeaway is that this FOA was intended to leverage the SBIR program to stimulate commercially oriented biomedical technology R&D that also advances national priorities around energy independence, efficiency, and renewable energy adoption. It offered multiple SBIR submission pathways to accommodate projects at different maturity levels and encouraged small businesses to frame energy impacts as a core design and performance objective alongside the biomedical value proposition. The full announcement and official application instructions were provided through the NIH grants guide webpage linked in the notice, and technical access issues were routed to the NIH Office of Extramural Research (OER) webmaster contact listed in the posting.
Frequently Asked Questions (FAQs)
What is the "Energy Efficiency and Renewable Energy System Technology Research and Development" opportunity?
It is an NIH Small Business Innovation Research (SBIR) grant announcement that encouraged U.S. small businesses to develop and validate technologies that connect biomedical research with energy efficiency or renewable energy systems. The goal was to stimulate commercially oriented biomedical technology R&D that also advances national priorities around energy independence and renewable energy adoption.
What is the Funding Opportunity Number (FON) for this announcement?
The Funding Opportunity Number is PA 09 100.
Which federal agency sponsored this opportunity?
The National Institutes of Health (NIH) sponsored the opportunity.
What program is this opportunity part of?
This announcement was part of the SBIR program. It also noted a companion announcement with the same scientific scope under the Small Business Technology Transfer (STTR) program.
What is the companion STTR announcement?
The companion STTR announcement is PA 09 101, using STTR mechanisms R41 and R42.
What types of projects were encouraged under this SBIR announcement?
Projects were encouraged when biomedical science and technology development meaningfully intersected with energy-related goals. Examples described included reducing energy consumption in health-related settings, improving the efficiency of biomedical devices or laboratory processes, or enabling renewable energy integration in biomedical or healthcare applications.
What law or policy driver is tied to this opportunity?
The announcement was aligned with the Energy Independence and Security Act of 2007 (Public Law 110-140), signed December 19, 2007. That law directs federal SBIR/STTR agencies to give high priority, whenever possible and appropriate, to R&D projects that improve energy efficiency or advance renewable energy systems.
What SBIR grant mechanisms were used?
The announcement used NIH SBIR grant mechanisms R43 and R44.
Which SBIR application tracks were supported?
Multiple SBIR tracks were supported: Phase I (early feasibility and proof of concept), Phase II (full R&D and development toward commercialization), Fast Track (a combined Phase I/Phase II submission intended to speed transition when a clear development path exists), and Phase II Competing Renewal (noted as NIH-only) for additional work beyond the initial Phase II when justified.
What is the purpose of SBIR Phase I in this announcement?
Phase I was positioned for early feasibility and proof-of-concept work for technologies linking biomedical needs with energy efficiency or renewable energy objectives.
What is the purpose of SBIR Phase II in this announcement?
Phase II supported fuller research and development and technology development steps oriented toward commercialization.
What is the Fast Track option?
Fast Track is a combined Phase I/Phase II submission route intended to speed the transition between phases when there is a clear development path.
What is a Phase II Competing Renewal in this context?
The announcement identified a Phase II Competing Renewal option (NIH-only) to support additional work beyond the initial Phase II when progress and remaining development needs justify further support.
Who was eligible to apply?
Eligibility was limited to U.S. small business concerns.
Is cost-sharing or matching required?
No. The opportunity stated there was no cost-sharing or matching requirement.
What type of funding instrument was used?
The opportunity used a grant instrument type.
How is the opportunity categorized in terms of funding?
It was categorized as discretionary funding.
What is the funding activity category listed for this announcement?
The funding activity category was listed under education and health, reflecting the biomedical focus even though it includes energy efficiency and renewable energy system relevance.
Did NIH specify a fixed number of awards or total funding amount?
No. NIH did not commit to a fixed number of awards or a specific total dollar amount in the summary provided. Awards were contingent on the availability of funds and the receipt of a sufficient number of high-quality, meritorious applications.
What factors determine how many awards are made?
The number of awards and total funding would depend on available funds and on the quality, duration, and cost structure of submitted proposals, consistent with typical NIH language emphasizing competition and scientific/technical merit.
Is this funding opportunity still active?
No. The announcement is archived and is no longer active.
When was the announcement posted and created?
It was posted and created on February 12, 2009.
What was the original closing date?
The original closing date was January 7, 2012.
When was the opportunity archived?
It was archived on February 7, 2012.
What does it mean that the FOA ran "in parallel" with an STTR announcement?
It means applicants could pursue essentially the same scientific topic space under either SBIR or STTR, but under different program rules. The summary notes SBIR generally centers the small business as the primary R&D performer, while STTR more explicitly requires collaboration with a nonprofit research institution.
What NIH program areas (CFDA listings) were associated with this announcement?
The announcement referenced multiple CFDA program areas, including: oral diseases and disorders (93.121), alcohol research (93.273), drug abuse and addiction (93.279), national center for research resources (93.389), blood diseases and resources (93.839), allergy/immunology/transplantation (93.855), microbiology and infectious diseases (93.856), biomedical research and research training (93.859), and aging research (93.866).
What does the broad set of CFDA areas suggest about NIH interest?
It suggests NIH was open to energy-related R&D concepts as long as they were grounded in biomedical research needs and aligned with an NIH institute or center mission.
Where were the official instructions and full announcement hosted?
The full announcement and official application instructions were provided through the NIH grants guide webpage linked in the notice.
Who was listed for technical access issues related to the posting?
Technical access issues were routed to the NIH Office of Extramural Research (OER) webmaster contact listed in the posting.
What was the main intent or takeaway of this FOA for applicants?
The intent was to leverage SBIR to stimulate commercially oriented biomedical technology R&D that also improves energy efficiency or advances renewable energy systems. Applicants were encouraged to treat energy impacts as a core design and performance objective alongside the biomedical value proposition.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: SMART Office Fiscal Year 2009 Adam Walsh Act Implementation Act Grant Program
Previous opportunity: Energy Efficiency and Renewable Energy System Technology Research and Development (STTR R41/R42)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 09 100
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 09 100) also looked into and applied for these:
| Funding Opportunity |
|---|
| Mechanisms of Alcohol and Nicotine Co Dependence (R21) Apply for PA 09 098 Funding Number: PA 09 098 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Mechanisms of Alcohol and Nicotine Co Dependence (R01) Apply for PA 09 099 Funding Number: PA 09 099 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Manufacturing Processes of Medical, Dental, and Biological Technologies (SBIR R43/R44) Apply for PA 09 113 Funding Number: PA 09 113 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Manufacturing Processes of Medical, Dental, and Biological Technologies (STTR R41/R42) Apply for PA 09 114 Funding Number: PA 09 114 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for the Treatment of Pregnant/Postpartum Women with Substance Related Disorders and/or In Utero Substance Exposed Neonates (R01) Apply for PA 09 106 Funding Number: PA 09 106 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Medications Development for the Treatment of Pregnant/Postpartum Women with Substance Related Disorders and/or In Utero Substance Exposed Neonates (R21) Apply for PA 09 107 Funding Number: PA 09 107 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| The Integrative Cancer Biology Program (ICBP) Centers for Cancer Systems Biology (CCSB) (U54) Apply for RFA CA 09 011 Funding Number: RFA CA 09 011 Agency: National Institutes of Health Category: Education Health Funding Amount: $2,000,000 |
| Clinical Research Curriculum Award (K30) Apply for RFA RR 09 006 Funding Number: RFA RR 09 006 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Research on Clinical Decision Making in People with or at Risk for Life Threatening Illness (R01) Apply for PA 09 122 Funding Number: PA 09 122 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Biobehavioral Methods to Improve Outcomes Research (R21) Apply for PA 09 126 Funding Number: PA 09 126 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Exploratory Grants for Behavioral Research in Cancer Control (R21) Apply for PA 09 130 Funding Number: PA 09 130 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Interventions to Improve Palliative Care at the End of Life (R01) Apply for RFA NR 09 004 Funding Number: RFA NR 09 004 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Incorporating Cost Effectiveness Analysis Into Factors Affecting Quality of Life Health Related Research (R01) Apply for RFA NR 09 005 Funding Number: RFA NR 09 005 Agency: National Institutes of Health Category: Education Health Funding Amount: $300,000 |
| Research on Clinical Decision Making in People with or at Risk for Life Threatening Illness (R21) Apply for PA 09 121 Funding Number: PA 09 121 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Biomedical Research on the International Space Station (BioMed ISS) (UH2/UH3) Apply for PAR 09 120 Funding Number: PAR 09 120 Agency: National Institutes of Health Category: Education Health Funding Amount: $150,000 |
| Building System Capacity for Implementing Evidence Based Practices in Substance Abuse Treatment and Prevention (R34) Apply for PA 09 105 Funding Number: PA 09 105 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Surveillance Using Health Claims based Data System (R03) Apply for PA 09 143 Funding Number: PA 09 143 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Cancer Surveillance Using Health Claims based Data System (R21) Apply for PA 09 144 Funding Number: PA 09 144 Agency: National Institutes of Health Category: Education Health Funding Amount: $275,000 |
| Cancer Surveillance Using Health Claims based Data System (R01) Apply for PA 09 145 Funding Number: PA 09 145 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Pilot and Feasibility Studies in Preparation for Drug Abuse Prevention Trials (R34) Apply for PA 09 146 Funding Number: PA 09 146 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 09 100", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.